167 related articles for article (PubMed ID: 21304035)
21. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
22. [Adverse effects of antidepressants and antimanics].
Tanaka T; Koyama T
Ryoikibetsu Shokogun Shirizu; 2003; (38):362-5. PubMed ID: 12877003
[No Abstract] [Full Text] [Related]
23. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
Puech A; Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
[TBL] [Abstract][Full Text] [Related]
24. Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use.
Forman MB; Sutej PG; Jackson EK
Tex Heart Inst J; 2011; 38(6):714-8. PubMed ID: 22199446
[TBL] [Abstract][Full Text] [Related]
25. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
26. Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
Bernstein CD; Albrecht KL; Marcus DA
Expert Opin Pharmacother; 2013 May; 14(7):905-16. PubMed ID: 23506481
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
[TBL] [Abstract][Full Text] [Related]
28. Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.
Miskovic M
Med Arch; 2015 Apr; 69(2):107-9. PubMed ID: 26005260
[TBL] [Abstract][Full Text] [Related]
29. Association between mirtazapine use and serious self-harm in people with depression: an active comparator cohort study using UK electronic health records.
Joseph RM; Jack RH; Morriss R; Knaggs RD; Butler D; Hollis C; Hippisley-Cox J; Coupland C
Evid Based Ment Health; 2022 Nov; 25(4):169-176. PubMed ID: 35246454
[TBL] [Abstract][Full Text] [Related]
30. SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.
Takano A; Halldin C; Farde L
Psychopharmacology (Berl); 2013 Mar; 226(1):147-53. PubMed ID: 23090625
[TBL] [Abstract][Full Text] [Related]
31. Antidepressants and the risk of suicidal behaviors.
Jick H; Kaye JA; Jick SS
JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
[TBL] [Abstract][Full Text] [Related]
32. [Probable Serotonin Syndrome and Withdrawal Symptoms Caused by Milnacipran].
Koshiishi T; Okuyama K
Yakugaku Zasshi; 2016; 136(12):1675-1679. PubMed ID: 27904101
[TBL] [Abstract][Full Text] [Related]
33. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.
Tignol J; Pujol-Domenech J; Chartres JP; Léger JM; Plétan Y; Tonelli I; Tournoux A; Pezous N
Acta Psychiatr Scand; 1998 Feb; 97(2):157-65. PubMed ID: 9517912
[TBL] [Abstract][Full Text] [Related]
34. Milnacipran for pain in fibromyalgia in adults.
Cording M; Derry S; Phillips T; Moore RA; Wiffen PJ
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008244. PubMed ID: 26482422
[TBL] [Abstract][Full Text] [Related]
35. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Muneoka K; Shirayama Y; Takigawa M; Shioda S
Neurochem Res; 2009 Mar; 34(3):542-55. PubMed ID: 18751896
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of milnacipran and paroxetine in outpatients with major depression.
Sechter D; Vandel P; Weiller E; Pezous N; Cabanac F; Tournoux A;
J Affect Disord; 2004 Dec; 83(2-3):233-6. PubMed ID: 15555719
[TBL] [Abstract][Full Text] [Related]
37. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
Schlienger RG; Fischer LM; Jick H; Meier CR
Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
[TBL] [Abstract][Full Text] [Related]
38. [Clinical tolerance of a new antidepressant -- milnacipran].
Regina W; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1999; 25(3):252-8. PubMed ID: 10434151
[TBL] [Abstract][Full Text] [Related]
39. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study.
Dandjinou M; Sheehy O; Bérard A
BMJ Open; 2019 Oct; 9(9):e025908. PubMed ID: 31575566
[TBL] [Abstract][Full Text] [Related]
40. Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran.
Arai M
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):137-8. PubMed ID: 12486290
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
